Endoluminal Sciences is an early stage venture capital-backed company, committed to the development of novel, platform technologies to dramatically enhance the clinical performance of endovascular prostheses. While the technology is foreseen to have its application to a range of vascular disease states, the immediate focus is the treatment of abdominal aortic aneurysms (AAAs).